Section Arrow
HAE.NYSE
- Haemonetics Corp
Quotes are at least 15-min delayed:2025/06/28 11:12 EDT
Last
 73.8
-0.97 (-1.30%)
Day High 
75.2 
Prev. Close
74.77 
1-M High
75.59 
Volume 
1.01M 
Bid
66
Ask
80
Day Low
73.4713 
Open
74.77 
1-M Low
66.42 
Market Cap 
3.59B 
Currency USD 
P/E 22.59 
%Yield -- 
10-SMA 71.49 
20-SMA 70.73 
50-SMA 67.03 
52-W High 94.985 
52-W Low 55.3 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
3.31/5.40
Enterprise Value
4.51B
Balance Sheet
Book Value Per Share
17.09
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
1.36B
Operating Revenue Per Share
25.80
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed:2025/06/28 11:12 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, thecompany operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.